Collagen thread boosts lymphedema surgery? stanford trial begins

NCT ID NCT05825157

Recruiting now Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special collagen thread called BioBridge to standard lymph node transfer surgery can better reduce arm swelling in people with lymphedema. About 60 adults with stage I-II arm lymphedema will be followed for 12 months to measure changes in limb volume. The goal is to see if the scaffold helps new lymphatic connections form, improving the surgery's success rate.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BioBridge scaffold (a thread-like collagen device) used alongside standard lymph node transfer surgery
What this could lead to: If it works, this could improve surgical outcomes for people with arm lymphedema, reducing swelling more effectively than surgery alone.
What could go wrong: This is a small, early-stage trial with only 60 people. The device is new, and it may not improve results or could cause complications like infection or scarring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHEDEMA ARM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHEDEMA ARM

Contacts and locations

Locations

Stanford Hospital and Clinics
RECRUITING

Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.